草药配方中的尼托胺杂质:风险和缓解策略的审查
Nunavath Raja Shekhar1, Krishnaveni Nagappan1, Madhu Tanya Singh2
1Department of Pharmaceutical Analysis, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, The Nilgiris, Tamil Nadu, India.
亚胺杂质 (NMI) 是药品和草药中的一个风险. 本综述涵盖了草药产品中NMI的原因,风险和预防策略,重点是质量控制和测试.
科学领域:
- 化学分析 化学分析
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 亚胺是药品中发现的致癌杂质,如ARB和PPI.
- 由于被污染的药物被召回和撤出市场,人们的担忧越来越大.
- 在草药中也检测到氨酸,对公共健康构成风险.
研究的目的:
- 审查草药配方中酸胺杂质 (NMI) 的原因和风险.
- 讨论在草药产品中预防NMI的科学策略.
- 强调在草药行业质量控制和测试的重要性.
主要方法:
- 在药品和草药产品中对尼胺污染的文献综述.
- 对有关NMI的起源,风险和控制的科学文献进行分析.
- 在草药中检测和预防尼胺的策略的综合.
主要成果:
- 草药中的尼胺污染是严重的公共卫生问题.
- 在草药配方中,各种因素有助于尼托胺的形成.
- 有效的测试和控制措施对于减轻NMI风险至关重要.
结论:
- 酸胺污染对草药安全性构成重大威胁.
- 在发布草药产品之前,彻底的测试和研究至关重要.
- 在草药配方中预防NMI需要科学策略和严格的质量控制.
更多相关视频
08:41Integration of Miniaturized Solid Phase Extraction and LC-MS/MS Detection of 3-Nitrotyrosine in Human Urine for Clinical Applications
Published on: July 14, 2017
11:14Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry
Published on: October 2, 2016
相关概念视频
2° Amines to N-Nitrosamines: Reaction with NaNO2
Physical Properties of Amines
Preparation of Amines: Reduction of Oximes and Nitro Compounds
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Drug Regulation
Drugs Affecting Neurotransmitter Synthesis
